BSECompany Update6d ago · 13 Aug 2026, 05:28 pm
Report of Monitoring Agency for the Quarter ended on June 30, 2026.
Shivam Autotech Ltd · 532776
✦ AI SummaryFundraise
Shivam Autotech Ltd has received a monitoring agency report from CARE Ratings Ltd for the quarter ended June 30, 2026, related to the preferential issue of optionally convertible debentures worth Rs. 120 crores.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shivam Autotech Ltd - 532776 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
67278c6d-c711-46c8-95c2-d3e6943bbc58.pdf
View document text
Date: August 13, 2026
The National Stock Exchange of India Limited The BSE Limited
Exchange Plaza, Bandra Kurla Complex, Phiroje Jeejeebhoy Towers
Bandra East, Dalal Street Fort
Mumbai – 400 051 Mumbai – 400 001
(Scrip Code – SHIVAMAUTO) (Scrip Code – 532776)
Sub: Monitoring Agency Report for the quarter ended June 30, 2026
Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, read with Regulation 41(2) and 173A of the Securities
and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please
find enclosed Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE Ratings
Limited.
You are requested to take the information on record and disseminate.
Thanking you.
Yours truly,
For Shivam Autotech Limited
Mehvish
Company Secretary and Compliance Officer
SHIVAM AUTOTECH LIMITED www. shivamautotech.com
CIN: L34300HR2005PLC081531
Registered Office: 10, 1st Floor, Emaar Digital Greens, Tower A, Sector 61, Tel: 0124-4698700
Golf Course Extension Road, Gurugram, Haryana-122102 Fax: 0124-4698798
No. CARE/NRO/GEN/2026-27/1090
The Board of Directors
Shivam Autotech Limited
Towe, A, 10
1st floor, Emaar Digital Greens, Sector-61
Gurgaon
Haryana-122001
August 10, 2026
Dear Sir,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the preferential issue of
optionally convertible debentures of Shivam Autotech Limited (“the Company”)
We write in our capacity of Monitoring Agency for the preferential issue of optionally convertible debentures for the
amount aggregating to Rs. 120 crores of the Company and refer to our duties cast under 162A of the Securities &
Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per
aforesaid SEBI Regulations and Monitoring Agency Agreement dated February 02, 2026.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Akhil Kumar
Associate Director
Akhil.kumar@careedge.in
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
Report of the Monitoring Agency
Name of the issuer: Shivam Autotech Ltd
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: No
(b) Range of Deviation: Not applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the
objects of the issue based on the information provided by the Issuer and information obtained from sources
believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent
verification of any information/ certifications/ statements it receives. This Report is not intended to create any
legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use
of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any
security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be
construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user
of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies
Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm
that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the
issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall
be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA
submitting their report to the issuer and before dissemination of the report through stock exchanges. These
sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s
Management/Board.
Signature:
Name and designation of the Authorized Signatory: Akhil Kumar
Designation of Authorized person/Signing Authority: Associate director
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
1) Issuer Details:
Name of the issuer : Shivam Autotech Ltd
Name of the promoter : Dayanand Munjal Investments Pvt. Ltd.
Industry/sector to which it belongs : Automobile & Auto components
2) Issue Details
Issue Period : February 10, 2026 to February 11, 2026 (Tranche -1: Rs. 75 crore) and
February 11, 2026 to February 12, 2026 (Tranche – 2: Rs. 45 crore)
Type of issue (public/rights) : Preferential issue
Type of specified securities : Optionally convertible debentures
IPO Grading, if any : Not applicable
Issue size (in crore) : Rs. 120 crore
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information /
certifications considered by Comments of the Comments of the
Particulars Reply
Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
The issue proceeds have been utilized in The Company had requested the
accordance with the objects given as per release of the funds lying in the
offer documents and unutilised amount escrow account during July
Management Certificate, CA has been maintained in the OCD escrow 2026. Upon receipt of the
Whether all utilization is as per the disclosures in Certificate, PAS-4 forms for account. requisite approvals, the funds
the Offer Document? Tranche-1 & 2, OCD However, there is delay in utilisation of were released and subsequently
Subscription Agreement issue proceeds towards each object as deployed towards the stated
follows: object in July 2026. Accordingly,
• The company was unable to the amount was utilized
deploy ₹5 crore (Part of immediately upon its release.
CARE Ratings Limited
Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off
Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022
Phone: +91-22-6754 3456
Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691
Source of information /
certifications considered by Comments of the Comments of the
Particulars Reply
Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
Tranche-2) towards long-term
working capital within the The Company completed the
stipulated fifteen days from repayment of the NCDs within
receipt of funds and applicable the stipulated timeline as
approvals, whichever is later. mentioned in the Offer
(Note-1) Document. As of March 31,
• Although ₹115 crore (Tranche 1 2026, an amount of ₹9.85 crore
& 2) was earmarked for was receivable by the Company
repayment of NCDs issued to towards reimbursement of its
ALPHA Alternatives Structured own funds that had been utilized
Credit Opportunities (AASCO) for the repayment of the NCDs.
within seven days of receipt of During the quarte
[Showing first 8,000 characters — download PDF for full document]